CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Rough Riders: 6 Positive Takeaways from Legalization

I’d like to start with the acknowledgement of everything good that’s happened during this decade-long royal ball sideshow. Whether we want to acknowledge the degree of foolishness and the feeling of lost years due to spinning, what we can’t forget is what went right.  Number 1: We can mostly talk about weed anywhere now.  The exclusivity of acting as a dark agent to the status quo has definitely been reduced. That was fun and is missed. More so with weed, because it has some benefits and a nonexistent direct body count. Anyone that has danced with the sale of substances that fully enslave people by effect, have inevitably, at least once or twice acted as a precursor to the hooded spirit with a scythe. There’s a cost when your game currency consists of drugs that make the soul easy to slaughter. This is a rare situation with cannabis users. Most cannabis mortalities seemed to be ‘wrong place, wrong time’ incidents. Some cannabis user low moments can be attributed to mental illness. This should be expected, look at the atomic cocktail the human race has become and the strange layers of past eras we have built a world upon.  Even with the full reality in scope, I think it’s safe to say, sugar has enslaved and destroyed more lives than cannabis, at least in this country. Number 2: The start of the industry brought in a lot of action. One of the results of the war on drugs is that beneficial or medical psychoactive plants were traded adjacent and within the economy of all things not allowed. A tenuous and stressed economic system but one that provided a way for a few to level up out of poverty or a lifeless middle class. An economic system with a high body count. That economy has enticed the lower echelon of first round investors for the state legalization efforts. Those who were willing to risk a lot. Most used the chaos to fleece millions from family offices, shareholders, or private money. Some wanted to be that guy in that movie they watched while hoovering through an eight ball and some just thought it was cool to be a part of bringing cannabis lawfully into the market. I’ve worked with a few of the latter. Good to see them but also sad to see them lose ambition as the layers of scummy rules and people wore on their net worth. Some are still here, stuck with too much in, grimace riding their way through it, sometimes with the help of the mortal drugs available on the market of all things not allowed. Regardless, a solid few made off with a few lifetimes of cash and a lot of us made a living. Number 3: Plant breeding and new strains have steered the market. This is largely due to a few brands that understood how aromatic associations with foods and candies and a terpy weed analogue could be packaged in a way that psychologically related cannabis with items in the pantry. Innocuous cartoon baked goods and candy boxes on shorts, hoodies, and backpacks splattered their way around the common city square. It worked so well even backpacks with cartoon images of backpacks that would theoretically hold the pastry comic art flowered filled mylars became a thing. This pantry trend did bottleneck a lot of the wide genetic expressions available for consumption but that is starting to shift as more markets with different smoker cultures continue to pop up from legal states coming online. The value of unique varieties is established and has become a path for growers, breeders, or selectors to create a place in the market no matter their footprint. It’s a lottery with popping seeds but there are more winners with cannabis than any other gamble if you can read the current room and predict the coming trends. Number 4: Good smoke is available to all more than ever. There is still a lot of bad flower and products, but it’s easier now than ever to find amazing flower and hash. The cannabis economy does prefer cost still over quality. People have less money, so getting passable flower for a low cost has now become the preference for most. This has also led to more people growing their own and learning the plant craft. Oregon, the barren wasteland for the small and medium sized business who were decimated with oversupply and a hemp rush that was mostly cloaked real weed farms is now left with numerous small growers, seed makers and plant selectors doing their thing carving out small customer bases while working other jobs. Not ideal if you want cannabis to be your only source of bacon, but it is something. A lot of us in California look north to Oregon, praying that this isn’t our fate but witnessing a lot of the same signs. Maybe the only hold out is that California has been a nucleus for good weed and novel genetics. It still is, but that will only hold up as long as California holds up as a myth machine for new trends. At the moment, the allure of the west coast seems to be fading even if most of the world still perceive it as the “home of the best weed”. Still amazing cultivators and plant makers still live here and as long as they keep participating and bringing new things to the market, us Californians, have a chance to ride another wave. Number 5: Even law enforcement is lobbying for federally legal weed. And they are growing and selling it as well. Which is where it gets a little sticky. If you weren’t growing during the medical era of proposition 215 in California, you might not be aware that law enforcement’s position on both sides of the fence was strong prior to recreational licensing. So this is nothing new. What is new is that we can talk about it. Prior if you were raided, caught a charge and won the case only to find that a portion or none at all of your confiscated cannabis products were returned to you would raise an eyebrow but you wouldn’t ask where it went. It should be no surprise that during this time many law enforcement officials allegedly would have side hustles with medical dispensaries moving confiscated products into the market under protected shops receiving a profit from the sales. It is a strange rub seeing former law enforcement on culturally relevant weed podcasts touting themselves as leaders in the legalization movement appropriating advocacy movements and tokenizing a few supposed victims of the war on drugs while leveraging a publicly traded company into the largest seat at the table. It feels like a Black Mirror episode. It accurately feels like modern America. A cascading of past, present and future narratives cased into a feel good virtue soapbox with a massive profit potential but the box is empty. There isn’t enough bleach, soap or cleanser that can wash away the long standing impact of doublespeak propaganda that has petrified like diseased mind particles from the era of prohibition and its beneficiary, law enforcement and big business. If former law enforcement wants to stick it to the war on drugs, it would feel virtuous only if there wasn’t a carrot hanging on their stick, but I am not sure that those from that culture have ever known a carrot without a stick. Clearly, the virtuous path here is to fight for change around cannabis without a profit motive. Fight for it to change, because it is the right thing to do. Fighting for it to change because you know at some point you’ll be able to sell your weed company to big pharma for a billion dollars is not virtuous, it’s more of the same.  Number 6: Cannabis legalization began during the golden age of social media, creating a platform for normalizing its use to the world. Social media has without a doubt made and broken many in the cannabis space. Mid 2010s it was a virtual Mecca for trends, genetics and determining market value for specific growers and strains. If you were able to launch a brand and sell it prior to 2019, there is little doubt that you have won some sort of success in this space. Post-pandemic, social media’s use has been weaponized more as businesses, partnerships and markets have faltered. As the algorithms elevate the more contentious content and more contentious scenarios played out with the bubble beginning to implode, social media around the cannabis industry is feeling more like a carbon fiber plated tube thousands of feet below its operating depth on a mission to view the sunken ship of a industry that could have been, only to implode before viewing the wreckage. Instead, many with some harboring resentments towards the current state get high by hiding behind anonymous accounts and picking apart with perverse humor the failed state still dressed up like a lipstick smattered pig. It wouldn’t be honest if I didn’t admit that my participation in this trend has been less than superfluous. I understand fully the small wins of highlighting the skullduggery with a post that warrants a painful laugh. I also know that posting a weed pic just gets you in trouble and as much as I would prefer to post cannabis pics, the drama always brings more conversation and engagement. It becomes a hard pinning role and leaves little room for mobility out of that position and the cost of cashing in for the engagement by low key trauma posting through targeting memes can limit how and who you will work with in the future. People just trucking through the noise with a ten year plan have little time to even look at the drama, but we cannot argue that social media is an effective weapon. I am just not sure that any of us have really earned the power to wield it and are free enough from our own bullshit to be the moral adjudicator of the cannabis space. This includes myself. Most here will just hustle that engagement for a profit, and in the end aren’t too far from the true intentions of law enforcement carrying on with a publicly traded weed company spouting cheap virtue aphorisms on justice. It’s really just a lot of spin encased in a virtual drug. Meanwhile the rappers and duffle bag boys keep grifting away to consumers who just want cheap or hype weed, never to be accepted by their peers who know and have felt their unscrupulous behavior, but without a doubt are still catching the bag for how much longer, I do not know. In any event, troll trauma posting is getting old and it’s time to start developing a new form of market creation and competition. These social low points are always the womb for new waves of creativity. Just make sure that you vet your corporate sponsors. This last point I know is a hard ask. There is much that is not functioning and when the losses keep stacking up an easy win is there with some online character assassination. My argument is that this trend will also lose its relationship with reality, where drama will be engineered to drive engagement. Trolling for some sort of change or awareness will just end up as a marketing strategy solely. Losing its power, like most things do, into the void of short term profitability. The muddy banks of an emerging industry held like a social experiment by the federal government, measuring whether they open up the market through descheduling or limiting its legal expansion by rescheduling within the world of big tobacco and pharmaceuticals, will use what we have created as a reference point for that decision. We still live under a master and they continue to act as one as long as we continue to buy what they sell. Right now, biotech companies and private equity are investing heavily in low THC genetically modified cannabis plants as a substitute for tobacco. I’m not sure how that will work, since nicotine is a far different stimulant and its legal yet regulated proliferation has almost fully negated the awareness and intentional use of its neurotrophic medical benefits that could be used in substitution of antidepressants and SSRIs. Like tobacco, will we lose the purposeful use of cannabis and its medical benefits while these Optimus Prime level industry actors descend into the chaos of the current state? I think it’s likely as more and more of reality continues to play out like the Twilight Zone. We can still resist this by continuing to organize into small thoughtful online groups, perhaps trolling more the meta than the individuals, unless of course the meta becomes an individual. A larger than life icon with the power to determine the industry trajectory as a whole, conspicuously breaking all the rules and continuing to get a pass from the powers that be. Those entities, icons, or organizations, should continue to be tested. As any power should be that could shape the future of our collective and individual dreams. They determine who or who doesn’t sit at the table, and that is also a power that is too great for one or a few, because in the end that power rules over them more than they rule over anything else, bringing forth a primal state of behavior. Behaviors that bury its passengers leagues under a weighted sea, shoddily wrapped in a glossy material that screams hubris.

https://hightimes.com/

Rough Riders

I’d like to start with the acknowledgement of everything good that’s happened during this decade-long royal ball sideshow. Whether we want to acknowledge the degree of foolishness and the feeling of lost years due to spinning, what we can’t forget is what went right.  Number 1: We can mostly talk about weed anywhere now.  The exclusivity of acting as a dark agent to the status quo has definitely been reduced. That was fun and is missed. More so with weed, because it has some benefits and a nonexistent direct body count. Anyone that has danced with the sale of substances that fully enslave people by effect, have inevitably, at least once or twice acted as a precursor to the hooded spirit with a scythe. There’s a cost when your game currency consists of drugs that make the soul easy to slaughter. This is a rare situation with cannabis users. Most cannabis mortalities seemed to be ‘wrong place, wrong time’ incidents. Some cannabis user low moments can be attributed to mental illness. This should be expected, look at the atomic cocktail the human race has become and the strange layers of past eras we have built a world upon.  Even with the full reality in scope, I think it’s safe to say, sugar has enslaved and destroyed more lives than cannabis, at least in this country. Number 2: The start of the industry brought in a lot of action. One of the results of the war on drugs is that beneficial or medical psychoactive plants were traded adjacent and within the economy of all things not allowed. A tenuous and stressed economic system but one that provided a way for a few to level up out of poverty or a lifeless middle class. An economic system with a high body count. That economy has enticed the lower echelon of first round investors for the state legalization efforts. Those who were willing to risk a lot. Most used the chaos to fleece millions from family offices, shareholders, or private money. Some wanted to be that guy in that movie they watched while hoovering through an eight ball and some just thought it was cool to be a part of bringing cannabis lawfully into the market. I’ve worked with a few of the latter. Good to see them but also sad to see them lose ambition as the layers of scummy rules and people wore on their net worth. Some are still here, stuck with too much in, grimace riding their way through it, sometimes with the help of the mortal drugs available on the market of all things not allowed. Regardless, a solid few made off with a few lifetimes of cash and a lot of us made a living. Number 3: Plant breeding and new strains have steered the market. This is largely due to a few brands that understood how aromatic associations with foods and candies and a terpy weed analogue could be packaged in a way that psychologically related cannabis with items in the pantry. Innocuous cartoon baked goods and candy boxes on shorts, hoodies, and backpacks splattered their way around the common city square. It worked so well even backpacks with cartoon images of backpacks that would theoretically hold the pastry comic art flowered filled mylars became a thing. This pantry trend did bottleneck a lot of the wide genetic expressions available for consumption but that is starting to shift as more markets with different smoker cultures continue to pop up from legal states coming online. The value of unique varieties is established and has become a path for growers, breeders, or selectors to create a place in the market no matter their footprint. It’s a lottery with popping seeds but there are more winners with cannabis than any other gamble if you can read the current room and predict the coming trends. Number 4: Good smoke is available to all more than ever. There is still a lot of bad flower and products, but it’s easier now than ever to find amazing flower and hash. The cannabis economy does prefer cost still over quality. People have less money, so getting passable flower for a low cost has now become the preference for most. This has also led to more people growing their own and learning the plant craft. Oregon, the barren wasteland for the small and medium sized business who were decimated with oversupply and a hemp rush that was mostly cloaked real weed farms is now left with numerous small growers, seed makers and plant selectors doing their thing carving out small customer bases while working other jobs. Not ideal if you want cannabis to be your only source of bacon, but it is something. A lot of us in California look north to Oregon, praying that this isn’t our fate but witnessing a lot of the same signs. Maybe the only hold out is that California has been a nucleus for good weed and novel genetics. It still is, but that will only hold up as long as California holds up as a myth machine for new trends. At the moment, the allure of the west coast seems to be fading even if most of the world still perceive it as the “home of the best weed”. Still amazing cultivators and plant makers still live here and as long as they keep participating and bringing new things to the market, us Californians, have a chance to ride another wave. Number 5: Even law enforcement is lobbying for federally legal weed. And they are growing and selling it as well. Which is where it gets a little sticky. If you weren’t growing during the medical era of proposition 215 in California, you might not be aware that law enforcement’s position on both sides of the fence was strong prior to recreational licensing. So this is nothing new. What is new is that we can talk about it. Prior if you were raided, caught a charge and won the case only to find that a portion or none at all of your confiscated cannabis products were returned to you would raise an eyebrow but you wouldn’t ask where it went. It should be no surprise that during this time many law enforcement officials allegedly would have side hustles with medical dispensaries moving confiscated products into the market under protected shops receiving a profit from the sales. It is a strange rub seeing former law enforcement on culturally relevant weed podcasts touting themselves as leaders in the legalization movement appropriating advocacy movements and tokenizing a few supposed victims of the war on drugs while leveraging a publicly traded company into the largest seat at the table. It feels like a Black Mirror episode. It accurately feels like modern America. A cascading of past, present and future narratives cased into a feel good virtue soapbox with a massive profit potential but the box is empty. There isn’t enough bleach, soap or cleanser that can wash away the long standing impact of doublespeak propaganda that has petrified like diseased mind particles from the era of prohibition and its beneficiary, law enforcement and big business. If former law enforcement wants to stick it to the war on drugs, it would feel virtuous only if there wasn’t a carrot hanging on their stick, but I am not sure that those from that culture have ever known a carrot without a stick. Clearly, the virtuous path here is to fight for change around cannabis without a profit motive. Fight for it to change, because it is the right thing to do. Fighting for it to change because you know at some point you’ll be able to sell your weed company to big pharma for a billion dollars is not virtuous, it’s more of the same.  Number 6: Cannabis legalization began during the golden age of social media, creating a platform for normalizing its use to the world. Social media has without a doubt made and broken many in the cannabis space. Mid 2010s it was a virtual Mecca for trends, genetics and determining market value for specific growers and strains. If you were able to launch a brand and sell it prior to 2019, there is little doubt that you have won some sort of success in this space. Post-pandemic, social media’s use has been weaponized more as businesses, partnerships and markets have faltered. As the algorithms elevate the more contentious content and more contentious scenarios played out with the bubble beginning to implode, social media around the cannabis industry is feeling more like a carbon fiber plated tube thousands of feet below its operating depth on a mission to view the sunken ship of a industry that could have been, only to implode before viewing the wreckage. Instead, many with some harboring resentments towards the current state get high by hiding behind anonymous accounts and picking apart with perverse humor the failed state still dressed up like a lipstick smattered pig. It wouldn’t be honest if I didn’t admit that my participation in this trend has been less than superfluous. I understand fully the small wins of highlighting the skullduggery with a post that warrants a painful laugh. I also know that posting a weed pic just gets you in trouble and as much as I would prefer to post cannabis pics, the drama always brings more conversation and engagement. It becomes a hard pinning role and leaves little room for mobility out of that position and the cost of cashing in for the engagement by low key trauma posting through targeting memes can limit how and who you will work with in the future. People just trucking through the noise with a ten year plan have little time to even look at the drama, but we cannot argue that social media is an effective weapon. I am just not sure that any of us have really earned the power to wield it and are free enough from our own bullshit to be the moral adjudicator of the cannabis space. This includes myself. Most here will just hustle that engagement for a profit, and in the end aren’t too far from the true intentions of law enforcement carrying on with a publicly traded weed company spouting cheap virtue aphorisms on justice. It’s really just a lot of spin encased in a virtual drug. Meanwhile the rappers and duffle bag boys keep grifting away to consumers who just want cheap or hype weed, never to be accepted by their peers who know and have felt their unscrupulous behavior, but without a doubt are still catching the bag for how much longer, I do not know. In any event, troll trauma posting is getting old and it’s time to start developing a new form of market creation and competition. These social low points are always the womb for new waves of creativity. Just make sure that you vet your corporate sponsors. This last point I know is a hard ask. There is much that is not functioning and when the losses keep stacking up an easy win is there with some online character assassination. My argument is that this trend will also lose its relationship with reality, where drama will be engineered to drive engagement. Trolling for some sort of change or awareness will just end up as a marketing strategy solely. Losing its power, like most things do, into the void of short term profitability. The muddy banks of an emerging industry held like a social experiment by the federal government, measuring whether they open up the market through descheduling or limiting its legal expansion by rescheduling within the world of big tobacco and pharmaceuticals, will use what we have created as a reference point for that decision. We still live under a master and they continue to act as one as long as we continue to buy what they sell. Right now, biotech companies and private equity are investing heavily in low THC genetically modified cannabis plants as a substitute for tobacco. I’m not sure how that will work, since nicotine is a far different stimulant and its legal yet regulated proliferation has almost fully negated the awareness and intentional use of its neurotrophic medical benefits that could be used in substitution of antidepressants and SSRIs. Like tobacco, will we lose the purposeful use of cannabis and its medical benefits while these Optimus Prime level industry actors descend into the chaos of the current state? I think it’s likely as more and more of reality continues to play out like the Twilight Zone. We can still resist this by continuing to organize into small thoughtful online groups, perhaps trolling more the meta than the individuals, unless of course the meta becomes an individual. A larger than life icon with the power to determine the industry trajectory as a whole, conspicuously breaking all the rules and continuing to get a pass from the powers that be. Those entities, icons, or organizations, should continue to be tested. As any power should be that could shape the future of our collective and individual dreams. They determine who or who doesn’t sit at the table, and that is also a power that is too great for one or a few, because in the end that power rules over them more than they rule over anything else, bringing forth a primal state of behavior. Behaviors that bury its passengers leagues under a weighted sea, shoddily wrapped in a glossy material that screams hubris.

https://hightimes.com/

Big Pharma Drug Makers Fined Over $82B in Violations Last Decade, Report Shows

It’s time for Big Pharma companies that were caught lying to the public to pay up.  A new report compiled by ConsumerShield suggests the past decade was defined by record-high settlements and penalties in the pharmaceuticals sector, totalling over $80 billion in fines and penalties. ConsumerShield’s report, “The Pharmaceutical Industry: Balancing Profits, Penalties, and Public Safety,” was published on Oct. 17, and it shows that the lion’s share of violations involve synthetic opioids that clearly cause dependence and are powerful enough to stop breathing. London Loves Business reports that the study shows that since 2010, the pharmaceutical industry has incurred $82.8 billion in penalties during over 500 instances of recorded violations due to drug and medical device safety non-observance, unapproved promotion of medical products, breaches of the False Claims Act, and other violations. The biggest culprit—Johnson & Johnson—clocked in with over 45 violation records during the study period, leading to a total of  $24.5 billion in penalties. Johnson & Johnson paid $18 billion USD in penalties over the past five years in opioid and talc cases alone. Next is Teva Pharmaceuticals with penalties of $8.5 billion, AbbVie with penalties of $7.1 billion, GSK plc with penalties of $5.6 billion, and Pfizer with penalties of $3.2 billion. The report also lists significant settlements, with one case standing out: the Purdue Pharma case, resulting in an order to pay $8.3 billion. On Oct. 21, 2020, the Department of Justice announced a massive fine culminating its criminal and civil investigations into the opioid manufacturer Purdue Pharma, and a civil resolution of its civil investigation into individual shareholders from the Sackler family.   Purdue and the Sacklers continued to market OxyContin and opioid products to over 100 health care providers despite the company knowing there was good reason to believe they were diverting opioids and reporting misleading information to the DEA to boost Purdue’s manufacturing quotas.  Hundreds of thousands of people overdosed and died in the process. Nearly 88% of opioid-involved overdose deaths involved synthetic opioids, and opioids were the cause of 80,411 overdose deaths in 2021—75.4% of all drug overdose deaths, the CDC reported in 2021 when overdoses peaked. Compare that to heroin overdoses, which caused just 9,000 overdoses in 2021 unless they were mixed with opioids. Almost ten times more OD’d on synthetic opioids. “The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths, in addition to those caused by illicit street opioids,” said Deputy Attorney General Jeffrey A. Rosen.  “With criminal guilty pleas, a federal settlement of more than $8 billion, and the dissolution of a company and repurposing its assets entirely for the public’s benefit, the resolution in today’s announcement re-affirms that the Department of Justice will not relent in its multi-pronged efforts to combat the opioids crisis.” Most of us know about the ravages of the opioid epidemic, but what’s the deal with talc? Pharmaceuticals can kill you in other ways. Talcum powder lawsuits claim consumers were diagnosed with cancer after using talc-based Johnson & Johnson baby powder. The ConsumerShield report kicks off with a solemn warning: “It is with a sense of urgency and responsibility that we delve deep into the prevailing paradigms of the pharma industry,” the report reads. “Our investigation is geared towards understanding whether the soaring profits are inadvertently overshadowing the paramount need for consumer safety, ethical promotions, and pioneering research initiatives. “The stark discrepancy between R&D investments and marketing expenditures, coupled with the persistence of unethical practices despite soaring penalties, necessitates a comprehensive examination of the industry’s commitment to ethical practices and consumer well-being.” ConsumerShield representatives say that what the data shows is disturbing. “The juxtaposition of soaring revenues and escalating penalties is alarming,” ConsumerShield Senior Analyst Jane Doe told London Loves Business. “But what’s even more disturbing is the obvious disparity between companies’ spending on research and development (R&D) and their enormous marketing budgets.” The False Claims Act is the federal government’s primary litigation tool in combating fraud against the government, and part of that includes consumer protections. “Pharmaceutical companies that have engaged in illegal off-label marketing or promotion of their drugs have paid the Government hundreds of millions of dollars as a result of Federal False Claims Act cases, often times brought by pharmaceutical sales representatives, sales managers, compliance officers, other pharmaceutical company employees, physicians, nurses and/or employees of hospitals or physician practices,” the False Claims Act Pharmaceutical Fraud summary reads. The report shows the repercussions of marketing opioids despite receiving warnings about its enormous deadly impact, notwithstanding the people who actually need opioids to deal with high levels of pain.

https://hightimes.com/

Roland Griffiths, Pioneer of Johns Hopkins Psilocybin Studies Dead at 77

A Johns Hopkins professor who championed groundbreaking new research into psychedelic substances passed away Monday from colon cancer at the age of 77. Dr. Roland Redmond Griffiths, according to a New York Times obituary, helped usher in a new era of psychedelic research during his time at Johns Hopkins by leading several studies regarding the ways in which psychedelic substances may help combat a myriad of mental health disorders.  Dr. Griffiths’ 2006 paper “Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance” was a first-of-its-kind study in which otherwise healthy adults were administered psilocybin in a controlled environment. 80 percent of the participants described their experience as “mystical,” that is holding the same weight or significance as the birth of a child or the death of a parent or an otherwise monumental life event. These effects lasted as long as years in some of the study participants, many of whom were interviewed by well-known author and advocate of psychedelics, Michael Pollan, for his book How to Change Your Mind, which was later adopted into a Netflix series. “Roland had such a sterling reputation as being a rigorous and conscientious scientist,” Pollan said in a phone interview with the New York Times. “No one of his stature had stepped into this area in such a long time that it gave a lot of other people confidence,” he added. “When he presented this completely weird study, which was so out there for science, it could have been dumped on, but it wasn’t.” The double-blind placebo-controlled study served as a baseline for dozens of subsequent studies on psychedelic substances, all of which have pretty poignantly indicated that psychedelics can potentially have massive, overwhelmingly positive effects on human beings. A cursory search of the phrase “psilocybin study” on High Times online will display dozens of studies showing promising results in psychedelic treatment for everything from depression to alcoholism, cigarette smoking, PTSD and more, almost none of which would have been possible without Dr. Griffiths’ initial work with psilocybin at Johns Hopkins. As one of the leading universities in the nation on medical research, it was easier to get approval there than it may have been elsewhere.  Dr. Griffiths’ work with psychedelic medicines continued from there with a study in which cancer patients receiving end-of-life care who were suffering from the anxiety of facing their own deaths were administered psilocybin. He received his own cancer diagnosis in 2021 and told the New York Times Magazine he opted to take a large dose of LSD for the purpose of exploring his cancer diagnosis and asking the cancer, point blank, if it was going to kill him. “The answer was, ‘Yes, you will die, but everything is absolutely perfect; there’s meaning and purpose to this that goes beyond your understanding, but how you’re managing that is exactly how you should manage it,’” Dr. Griffiths said to the New York Times Magazine. “Western materialism says the switch gets turned off and that’s it, but there are so many other descriptions. It could be a beginning! Wouldn’t that be amazing.” According to the New York Times obituary, Dr. Griffiths was born July 19, 1946 in Glen Cove, New York to parents William and Sylvie Griffiths. He received his education at Occidental College in Los Angeles where he majored in psychology and at the University of Minnesota where he studied psychopharmacology. He received his doctorate degree in 1972, after which he was hired by Johns Hopkins University where his research focused on drug use and addiction. Dr. Griffiths authored and contributed to several other studies related to drug use during his time at Johns Hopkins, including a widely-circulated study on caffeine addiction in the early 90’s which was the first to describe chronic caffeine use as similar to if not the same as classical forms of addiction. Dr. Griffiths’ research on caffeine was among the first to show that it could be considered an addictive substance with uncomfortable and unpleasant withdrawals and that caffeine addiction was a “clinically meaningful disorder.” Dr. Griffiths also contributed work to studies on opiate use, cocaine, nicotine and more.  Dr. Griffiths is survived by his wife, Marla Weiner, as well as his three children, five grandchildren and two siblings. At the time of his death, the New York Times said he was working on a paper based on another study where priests and other members of religious orders were given high doses of psilocybin to see if the experience could affect the deeply religious in similar ways as it had the subjects in his previous studies. “A hallmark feature of these experiences is that we’re all in this together,” Dr. Griffiths said in an interview with the Chronicle of Higher Education earlier this year. “It opens people up to this sense that we have a commonality and that we need to take care of each other.”

https://hightimes.com/

Old, Unused Lumber Facility in Minnesota Set To Become Cannabis Cultivation, Manufacturing Facility

One company called HWY35, LLC, currently based in Missouri, recently received funds from the Minnesota Department of Iron Range Resources and Rehabilitation’s Advisory board (IRRR) voted 5-3 to approve a loan to be used to build a cannabis cultivation and manufacturing site in Grand Rapids, Minnesota. The department’s goal is “…to invest in resources to foster vibrant growth and economic prosperity in northeastern Minnesota by enhancing livable communities, maximizing collaborations and partnerships and strengthen businesses and worker education.” It provides low or no interest loans and grants to businesses who plan to relocate into Minnesota, or are currently based in the state and are seeking to expand. The department recently approved a $10 million loan for HWY35 to build a cannabis grow and manufacturing facility in Grand Rapids. “While launching the cultivation and manufacture of cannabis products as a new industry in the state of Minnesota is exciting, the opportunity to create positive economic impacts in northeastern Minnesota and, in particular the Grand Rapids and greater Iron Range communities, for generations to come is both thrilling and rewarding,” said HWY35 Lead Minnesota Investment Partner, John Hyduke. “We will revitalize the 138-acre former Ainsworth site into a high-tech, state-of-the-art, cannabis cultivation and manufacturing facility that our communities will be proud of and that will serve as an industry leader for the state of Minnesota.” According to Rob Mattei, City of Grand Rapids Director of Community Development, HWY35 has exhibited great success in operating cannabis facilities in similar states as well, which is why their proposal was approved. The property was once home to Canada-based Ainsworth Lumber Company, which made oriented strand boards used in single-family home construction. The company initially bought the Grand Rapids location in 2004, which it sat idle as of 2006, and closed permanently in 2008. According to the Grand Rapids Herald Review, the house market was part of the reason for the closure. At its peak, 190 people were employed at the facility. HWY35 on the other hand estimates it will create hundreds of new jobs with its cannabis business, according to IRR Commissioner Ida Rukavina. “The HWY35 project is expected to benefit northeastern Minnesota through the creation of 400 jobs and increased tax revenues that can be reinvested back into the region,” Rukavina said. “Because the project is based in both manufacturing and agriculture, it has the potential to significantly diversify the local economy, which is one of our agency’s primary goals.” According to MPR News, the jobs will pay an average of $24 an hour, and offer a range of salaries between $40,000 to $160,00 per year. HWY35’s licenses are not in hand yet, but IRRR director of business development, Mathew Sjoberg, said that they should be up and operating by the end of 2024. Rukavina told MPR News that approving cannabis in the area will help add diversity to the region’s industries, mainly mining and timber. “We know that not everyone may agree with this type of industry,” said Rukavina. “But it is now legal in the state of Minnesota. This type of manufacturing, if it doesn’t happen here, it is going to happen somewhere else in our state.” The IRR and HWY35 came to the agreement that $5 million of the loan will be forgiven if the company can reach 150 employees within five years, or 175 employees within the next 10 years. Of course, there is traditionally opposition from some parties regarding the growth of cannabis in a new market. Minnesota Rep. Ben Davis said that he used cannabis in his youth, and claims that it is addictive. “I’m absolutely for free market capitalism,” said Davis. “But that does not mean I need to put my stamp of approval on us taking $10 million of people’s money, of government money, and putting it towards basically subsidizing this industry.” Sen. Justin Eichorn also opposed the public financing support, and said that the public should have been able to voice their opinion about how the money was being used. “I’m surprised it’s going to take darn near 33 percent of the total project cost and government money to get this thing off the ground, based on conversations I had with other people that are in the industry and other states,” Eichorn said. HWY35’s IRRR loan application stated that this was a “remarkable market opportunity,” and that “industry is poised for explosive growth, offering an unprecedented chance for HWY35 to become a dominant force in the emerging market.” Recreational cannabis is new in Minnesota, thanks to Gov. Tim Walz signing a cannabis legalization bill in May. “We’ve known for too long that prohibiting the use of cannabis hasn’t worked. By legalizing adult-use cannabis, we’re expanding our economy, creating jobs, and regulating the industry to keep Minnesotans safe,” Walz said. “Legalizing adult-use cannabis and expunging or resentencing cannabis convictions will strengthen communities. This is the right move for Minnesota.” The program began on Aug. 1, but dispensaries won’t be ready for at least a couple of years.

https://hightimes.com/

Harlem’s First Dispensary Opens to Customers

After months of controversy and legal disputes, the first legal cannabis dispensary in Harlem opened its doors to customers on Wednesday.  Gotham Buds celebrated its grand opening on West 125th Street in Manhattan –– just across the street from the historic Apollo Theater.  According to CBS New York, the store is the “the 26th conditional adult-use retail dispensary to open in New York State,” as well as the first state-licensed dispensary to open in the iconic neighborhood with a rich history of music and the arts. It has been a long road to opening for Gotham Buds, marked by fits and starts.  A local business group, the 125th Street Business Improvement District, filed a lawsuit in April challenging the opening of the shop, contending that “the process was conducted secretly in order to avoid opposition from the community.” The group also raised concerns about the cannabis store’s location relative to a neighborhood school. “We’ve taken this action to really create transparency and to create a channel of communication to understand why this location,” Mukaram Taheraly, the chairman of the 125th Street Business Improvement District, said then. Barbara Askins, president of the 125th Street Business Improvement District, said that the group believes “this location is bad for our children.”  But the lawsuit was dismissed in August after a “judge ruled the business across from the Apollo Theatre is exempt from an injunction blocking the Office of Cannabis Management from opening any other dispensaries while a lawsuit proceeds against its licensing program,” according to CBS New York. The judge’s ruling set the stage for a grand opening that was tentatively scheduled for September 5, but the date was ultimately kicked to this week. “Harlem isn’t just our location — it’s our community, our commitment. We’re here to grow roots and become a pillar of dreams realized,” Jeffrey Lopez, an owner of Gotham Buds, said in a statement, as quoted by the New York Daily News. “It’s all about passion, vision and a purpose bigger than ourselves.” The state’s allocation of recreational cannabis dispensary licenses has drawn other legal challenges, too. In August, a New York judge slapped an injunction on the process, temporarily pausing the awarding of licenses after a lawsuit was filed by a group of veterans. The veterans challenged the state’s policy of awarding the first round of licenses to individuals with prior pot-related convictions.  That policy was announced last year by New York Gov. Kathy Hochul. “New York State is making history, launching a first-of-its-kind approach to the cannabis industry that takes a major step forward in righting the wrongs of the past,” Hochul said in her announcement of the initiative. “The regulations advanced by the Cannabis Control Board today will prioritize local farmers and entrepreneurs, creating jobs and opportunity for communities that have been left out and left behind. I’m proud New York will be a national model for the safe, equitable and inclusive industry we are now building.” According to the Daily News, the judge who heard the veterans’ case “ruled that the state’s Office of Cannabis Management had failed to comply with the court, undoing the exemption and leaving shops like Gotham Buds in limbo,” but that, “in yet another twist, Gotham Buds and four other dispensaries were cleared to open.” More from the Daily News on Gotham Buds’ opening: “Gotham Buds is now one of 11 legal pot shops in the five boroughs. However, there are thousands of unlicensed shops in the city that have ducked state rules and regulations to sell their ganja. The injunction was not the only hurdle the Harlem store had to jump through. Earlier this year, the dispensary faced intense community backlash and was slapped with a lawsuit from a local group of businesses who said the shop would attract crime, add to congestion and encourage drug use in an area already plagued with all three. The application window for nonconditional cannabis business licenses — for the general public — opened on Oct. 4 and will remain open until early December. The newly expanded program will take applications for new retail shops, farms, processing plants and microbusinesses.” More than two years after New York legalized recreational cannabis for adults, the new legal weed market continues to take shape.  The law was enacted by former New York Gov. Andrew Cuomo. After Cuomo stepped down amid allegations of sexual misconduct, he was succeeded by Hochul, who went right to work in getting the legal weed market up and running.  Adult-use cannabis sales officially began in December, when the state’s first legal dispensary opened in Manhattan’s East Village neighborhood. “We set a course just nine months ago to start New York’s adult-use cannabis market off on the right foot by prioritizing equity, and now, we’re fulfilling that goal,” Hochul said in a statement at the time. “The industry will continue to grow from here, creating inclusive opportunity in every corner of New York State with revenues directed to our schools and revitalizing communities.”

https://hightimes.com/

Lawsuit Aims To Block Cops From Smoking Pot in New Jersey

If employees who drive buses, operate forklifts, and work with hazardous equipment aren’t allowed to test positive for pot should the police? After New Jersey’s Attorney General said that law enforcement officers can consume pot off-duty last year, a lawsuit aims to block officers on police forces from consuming cannabis, even off the clock. The New Jersey Monitor reports that Jersey City Public Safety Director James Shea, filed an 18-page complaint on Oct. 16, arguing that because federal law prohibits anyone who uses a controlled substance including cannabis from possessing a firearm, Jersey City cannot employ police officers who consume adult-use cannabis. Shea was joined in his announcement with Mayor Steven Fulop and Jersey City Police Department officials. The State of New Jersey, Matthew Platkin as Attorney General of the state of New Jersey, The New Jersey Civil Service Commission, Norhan Mansour, Omar Polanco, Mackenzie Reilly, Montavious Patten, and Richie Lopez are listed as the plaintiffs.  The lawsuit argues that federal law prohibits police officers from carrying ammunition, thus making them ineligible to be police officers. “The Federal Gun Control Act […] prohibits regular users of controlled dangerous substances, including marijuana/cannabis, from possessing or receiving firearms and ammunition,” the lawsuit reads.  “Police officers in New Jersey are required to possess and receive firearms in order to fulfill their duties as law enforcement officers. New Jersey legalized the regulated use of recreational marijuana/cannabis in New Jersey through passage of the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMM Act). In doing so, New Jersey failed to address the impact of the federal firearm laws on the use of regulated marijuana/cannabis in New Jersey for persons who are required to possess and/or receive firearms or ammunitions as part of the job duties, including police officers in Jersey City.”  The lawsuit clarified where specifically the law would need to be applied. “This action seeks a declaration pursuant to 28 U.S.C. § 2201, that the CREAMM Act and specifically N.J.S.A. 24:6I-52(a)(1) is preempted as it applies to adverse employment action to any individual who is an unlawful user of any controlled substance, including marijuana/cannabis, where such person is required to possess and/or receive a firearm or ammunition as part of his or her job duties.”  Shea defended his reasoning in challenging police officers’ eligibility based on testing positive for cannabis. “Every citizen in the state of New Jersey has the right to use marijuana,” Shea told the media at Jersey City’s public safety headquarters. ”If one of our officers wants to do that, they could smoke as much as they want—they can no longer perform the duties of a police officer, and we will have to terminate them if we become aware.” In April 2022, Attorney General Matt Platkin told law enforcement officials in New Jersey that state law requires them to allow officers to consume cannabis off-duty. This law was recently challenged in Jersey City: The state Civil Service Commission concluded that Jersey City must rehire a police officer who was fired after she tested positive for cannabis. At least three other officers fired for the same reason have also challenged their terminations, the New Jersey Monitor reports. The CREAMM Act was passed on December 27, 2020. The CREAMM Act authorizes the state’s Cannabis Regulatory Commission (CRC) to expand the existing Medicinal Cannabis Program, and develop, regulate, and enforce adult-use rules and activities. Shea added at the press conference that the CRC is “refusing to acknowledge the conflict between the federal law and the state law.” The lawsuit highlights the supremacy clause of the U.S. Constitution, banning states from overriding federal statutes. “We all agree that they smoked, they utilized marijuana, cannabis, or THC. We all agree that they would need to carry a firearm to be police officers,” he said. “So it should be as simple as a judge clarifying the supremacy clause.” Shea said the officers who were fired were all offered jobs in his department that did not involve guns, but the city refused to give them their old jobs back. He added that they were fired not because they used cannabis but because they can no longer carry a firearm, thus becoming ineligible to be police officers. The commission argued that there is no basis in the state’s adult-use cannabis law, the CREAMM Act, which allows employers to fire someone who uses cannabis outside of the scope of work on the clock, meaning Jersey City can’t fire officers who simply test positive for cannabis because they could have smoked weeks ago. The decision aligns with the Bureau of Alcohol, Tobacco, Firearms and Explosives, which said last March that people who consume cannabis are ineligible to possess firearms or ammunition under the federal Gun Control Act of 1968.

https://hightimes.com/

Vermont High Schools Float Getting Honest with Students About Legal Pot

You can’t ignore the elephant in the room—that is, that cannabis is now legal in Vermont and sold to adults, and it’s only a matter of time until high school students are fully aware of their future options when they become adults. WCAX in Vermont profiled various school officials to probe what their plans are and how the conversation around cannabis will continue, now that sales are legal for adults. “Acknowledging that marijuana laws have changed—it’s for sale—so we take a really nuanced view here, which is talking to them about the realities of situations, but also talking to them about where they’re at in their actual lives,” Matt Meunier, a student assistance programming counselor at Champlain Valley Union High School in Hinesburg, Vermont, told WCAX. Chittenden County—home to Champlain Valley Union High School—is also home to at least 10 cannabis retail stores, and school officials can’t keep pretending that they don’t exist. “Talking about decision-making, what choices you want and what life you want to live helps take it away from just, ‘Hey, this is all available to you now,’ to what type of member of my community do I want to be? What are my habits?” said Meunier. Meunier said there are more ways to consume cannabis now, but that there hasn’t been a noticeable increase in student use. “I think the longer that students put off using for the first time or experimenting for the first time, the easier it gets for them to make those choices and the healthier it will be for them at the end,” said Meunier. Kelly Dougherty with the Department of Health said that Vermont has the second-highest percentage of people nationwide aged 12 to 17 reporting using cannabis in the past 30 days—but that it’s ultimately up to parents to teach their kids about cannabis, among other things. The results of a Monitoring the Future (MTF) Survey, conducted by the University of Michigan, were released on Dec. 16, 2015 by the university and the National Institute on Drug Abuse (NIDA). The study revealed that daily cannabis use among high school seniors has “changed little since 2010,” despite the advent of legalization in several states and its consideration in many others. Another interpretation of the study, however, notes that cannabis use becoming more popular than tobacco use, because for the first time “more high school seniors smoke marijuana daily than cigarettes.” “Parents are the number one influence on their kids. Our kids are watching us all the time and they model the behavior that they see. So, even with alcohol, we recommend that if parents are using alcohol, keep it kind of out of sight and talk to your kids about the risks of it,” said Dougherty. The main concern appears to be curbing underage use until they are old enough to decide on their own. “We like to focus on helping youth develop healthy coping strategies, again, protecting brain health so they can be their best selves. Just because something is legal doesn’t mean it’s safe,” said Dougherty. On Jan. 22, 2018, Gov. Phil Scott signed the adult-use cannabis bill into law, which made Vermont the ninth state in the nation at the time to have legalized cannabis for both medical and recreational purposes. Starting July 1, 2018, adults living in Vermont were permitted to possess up to one ounce of cannabis, as well as grow up to six plants.  It would take over a year for retail sales to launch in the state. In 2020, Vermont became the 11th state to tax and regulate cannabis for adults. Two years later, sales figures are beginning to show the rewards. Adult-use cannabis sales officially launched in Vermont recently, with stores in three communities opening their doors to customers. Under Vermont law, a portion of the excise tax revenue is allocated to fill any deficit in the control board’s budget. Of the excise tax revenue, 70% goes to the state general fund, and 30% goes towards substance abuse and prevention funds. Cannabis sales tax revenue is earmarked for after-school and summer learning programs. Vermont’s adult-use cannabis industry took off with a bang. According to the Vermont Department of Taxes, Vermont cannabis stores sold $2.6 million worth of product in October, the first month of legal cannabis sales. James Pepper, chair of the Vermont Cannabis Control Board, said that $2.1 to $2.4 million in excise taxes could be collected during the first nine months of cannabis sales. That translates to around $233,000 to $267,000 per month. “They look pretty much like our projections were accurate,” Pepper said. Vermont legalized personal possession and cultivation of cannabis for adults back in 2018. The state legalized medical cannabis in 2004.

https://hightimes.com/

Study Finds Psilocybin Use Associated With Mental Health Benefits

A new study has found that using psilocybin outside of a clinical setting was associated with mental health benefits including decreases in anxiety and depression. The research, which was published last month in the journal Frontiers in Psychiatry, studied nearly 3,000 people who reported on their experience taking psilocybin mushrooms.  To conduct the study, which is reportedly the largest study of psilocybin in a naturalistic (non-clinical) setting, researchers spent two years collecting data from 2,833 participants who planned to take psilocybin for purposes of “self-exploration.” Most participants were college-educated white men in the United States who had previous experience taking psychedelic drugs. The study participants were asked to fill out five surveys as part of the research. The first survey was completed two weeks prior to the psilocybin experience, which usually consisted of ingesting dried mushrooms, and again the day before the planned psychedelic trip. The remaining surveys were taken one to three days after the experience, two to four weeks after and two to four months after taking the drug.  Not all of the participants who took the initial survey completed all five surveys, however. Of the nearly 2,833 participants who completed the initial survey two to four weeks before taking psilocybin, 1,182 completed the survey two to four weeks later, and 657 completed the final follow-up survey two to three months after their psilocybin experience. Upon analyzing the data from the surveys, the researchers determined that participants reported long-lasting reductions in anxiety, depression, alcohol misuse, neuroticism and burnout. Additionally, the participants reported improvements in cognitive flexibility, emotion regulation, spiritual well-being and extraversion. Not all of the study participants reported positive experiences, however. The researchers noted that a minority of subjects reported “persisting negative effects” following the psilocybin experience. Two to four weeks after taking psilocybin, 11% of survey respondents reported experiencing mood fluctuations and depression, while 7% reported such symptoms two to four months after the experience. Overall, the authors of the study reported generally positive experiences among the participants, leading them to call for further research into the potential mental health benefits of psilocybin therapy. “Though the findings reported here are generally positive in nature, questions remain about for whom such use may pose unnecessary risks, mechanisms underlying the persisting changes observed, and in what ways psilocybin’s unique profile of pharmacological effects may be optimally harnessed in clinical or other settings, presenting critical directions for future investigation,” the authors of the study wrote. Studies conducted by Johns Hopkins and other researchers have shown that psilocybin has the potential to be an effective treatment for several serious mental health conditions, including PTSD, major depressive disorder, anxiety and substance misuse disorders. A study published in 2020 in the peer-reviewed journal JAMA Psychiatry found that psilocybin-assisted psychotherapy was a quick-acting and effective treatment for a group of 24 participants with major depressive disorder. Separate research published in 2016 determined that psilocybin treatment produced substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer. Federal agencies including the Food and Drug Administration are currently reviewing the potential for psychedelics to treat serious mental health conditions. In May 2022, the head of the Substance Abuse and Mental Health Services Administration wrote to U.S. Representative Madeleine Dean, a Pennsylvania Democrat, that FDA approval of psilocybin to treat depression was likely within the next two years. As the nation faces rising rates of substance use and mental health issues “we must explore the potential of psychedelic-assisted therapies to address this crisis,” Miriam E. Delphin-Rittmon, assistant secretary for mental health and substance use, wrote to Dean. The ongoing research has prompted several states to consider legislation to ease the prohibition on psilocybin and other psychedelic drugs, particularly for therapeutic purposes. Last month, Oregon officials issued the state’s first license for a psychedelic therapy treatment center following the legalization of magic mushrooms for therapeutic use with the passage of a 2020 ballot measure. A similar initiative was approved by Colorado voters in 2022. California could be the next state to decriminalize psychedelics. Earlier this month, Governor Gavin Newsome vetoed a bill that would have decriminalized the possession and use of natural psychedelics including dimethyltryptamine (DMT), mescaline (except for peyote), and psilocybin and psilocin, the primary psychoactive ingredients in magic mushrooms, by adults aged 21 and older. Although he vetoed the measure, at the same time he called on state lawmakers “to send me legislation next year that includes therapeutic guidelines” for psychedelics. The new study, “Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey,” was published in September by the peer-reviewed journal Frontiers in Psychiatry.

https://hightimes.com/

Arizona Department of Revenue Release Cannabis Sales Data for June, July

The Arizona Department of Revenue recently released new data about cannabis sales reported for the months of June and July. Medical cannabis sales started in Arizona back in December 2012, while recreational cannabis sales started in Arizona in January 2021, but recent data shows that both industries have been experiencing a gradual decrease in sales. For medical cannabis during the month of June, sales dipped to $28 million followed by a downward trend of $26.1 million in July, which the Arizona Mirror reports as the lowest sales number for medical cannabis since recreational sales began. Within the past 30 months, medical cannabis sales have only fallen below the $30 million mark five times—all of which were recorded in 2023. This includes the months of January, February, May, June, and July, while sales in March and April remained above $30 million. The highest amount of medical cannabis sales that the state has collected in its history of sales was in April 2021 with $73.4 million, and other monthly sales data shows a decrease in sales, such as July 2022 with $40 million. These steady decreases in medical sales are seen alongside slight increases in recreational sales. In March 2023 recreational sales reached $99.9 million, while April recreational sales hit $90.1 million. However, June sales data shows a decrease to $85 million, followed by $77 million in July. The total amount of money collected from total cannabis sales in 2022 was $1.4 billion (medical brought in $500 million, and recreational hit $9.50 million). Since January 2021, the state has collected $1.5 billion in medical cannabis sales, while recreational sales made more than $2.2 billion within the same time period. Year-to-date data shows that so far between January-July, Arizona has collected a total of $207 million in medical cannabis sales, and $621 million in recreational cannabis sales. So far, the data reviews how recreational cannabis has reached new heights while medical cannabis sales gradually decrease, but both markets have been trending downward overall since March 2023. Data for state excise taxes show that recreational cannabis has generated more than $208.2 million in 2023 (so far), which is an increase compared to excise tax data for 2021. The department shows that adult-use cannabis generated $32.9 million over the course of 11 months, followed by $132.8 million in 2022. In overall cannabis excise taxes, Arizona has collected more than $360 million. State law requires that one third of cannabis excise taxes go toward community colleges, while 31% goes toward public safety as well as law enforcement and fire departments. Additionally, 25% is given to the Arizona Highway User Revenue Fund, which is distributed to various cities and towns to improve highway construction and other related expenses. Finally, 10% of cannabis taxes are put into the justice reinvestment fund, which can be used for various substance abuse programs, workforce development, but also to accomplish other goals such as helping residents expunge their criminal records. Cannabis patient card numbers are collected by the Arizona Department of Health Services, which recently reported that there were 126,938 cardholders in July, and 124,496 in August. The state’s highest number of cardholders was recorded in January 2021 with 299,054 patients. The department also shared that during the month of August, medical cannabis patients bought 4,719 pounds of various cannabis products. Between January and August, patients have purchased 37,979 pounds. Even though medical cannabis sales have decreased, it hasn’t stopped patients from using it to treat their various medical conditions. In March, a bill was introduced to add autism and post-traumatic stress disorder to the list of qualifying conditions, and was passed by the House in June. A year ago in 2022, more than 1,450 Arizonians were pardoned from their past federal cannabis possession convictions between 1992-2021, as directed by the Executive Order announced by President Joe Biden. According to Arizona attorney Jonathan Udell, this was a welcome change for people whose convictions have been on their record for decades. “I think there’s a lot of people out there that really feel the sting of being branded a non-law-abiding citizen,” Udell said. “And this sends a very big message to those people that you’re not a bad person because you smoked a plant one time that grew out of the ground or possessed some grass in your pocket.” While the industry keeps a close eye on the performance of both medical and recreational cannabis, other substances being researched for medical use are also continuing to grow. Earlier this year in May, an Arizona veteran was facing prison time for trying to treat his cluster headaches with DMT. “It’s the worst pain I’ve ever felt in my life,” Laetzsch said about the headaches. “Nothing helps the headache as well as DMT when I’m actually having it. It will abort the headache immediately. A small hit will abort the headache for about an hour to an hour and a half. If I take a bigger hit it can last longer but some of the headaches last a few hours so I would have to take a few hits during that episode. But, I would be pain-free. It wasn’t even a psychoactive amount that I smoked to abort the headache.” Currently, DMT is illegal in Arizona. Psilocybin is also illegal in the state, although recent legislation has been introduced to allow research to be conducted on the substance.

https://hightimes.com/

THC-M Cannabinoid: Everything You Need to Know

Lots of new cannabinoids have been popping up in the last few months, proving that the hemp market isn’t going anywhere.  With lots and lots of THC-based cannabinoids hitting the market one week after another, it’s easy for some to get lost in the mix.  But, one that you might want to keep an eye out for is THC-M, which is unlike any other cannabinoid we’ve talked about so far.   THCM may also be one of the least understood hemp derivatives so far, which means that it’s hard to talk about it in much detail, or even offer a clear picture of what kinds of effects it can offer.  However, what we do know shows a lot of promise, and may be something you really want to add to your cannabinoid rotation.  We’re going to examine THCM products to help hemp enthusiasts understand why this unique derivative really is a game changer that you may be missing out on without realizing it. You can also use the code HIGHTIMES25 for 25% off your order of THCM with fast and free shipping from Binoid. One of the best brands in the THC space. THC-M (Tetrahydrocannabinol Monomethylether) THC-M was first discovered in 1997, not as an isolated cannabinoid, but as a compound found in cannabis smoke.  It was used as a biomarker to identify possible in-utero exposure to cannabis, for up to 5 months before birth. THC-M has never been isolated, in fact, although we know that it is a naturally occurring, trace cannabinoid.   It’s actually a cannabinoid with zero research behind it, but it is determined to be a naturally degraded form of THC that results from aging plant material.  We also aren’t sure if it’s technically a metabolite of THC or not.  Of course, that hasn’t stopped hemp brands from using isomerization techniques to turn CBD into THC-M, through the rearranging of molecules, because what we do know about THC-M makes it worth creating for the general public of cannabinoid consumers. Naturally, the first question on most cannabis users’ minds is whether or not THC-M can get you high.  And, we actually don’t know. As of now, it doesn’t look promising. THC-M doesn’t seem to have any psychoactive capabilities according to the little we know about its chemical structure.  But, at the same time, if you’ve come across it on the market, you’ve seen it being sold in vape form. You’ll notice that vapes that contain THC-M also contain psychoactive cannabinoids like THC-P, delta 8, HHC, etc.  So, what is the THC-M actually contributing?  While THC-M is likely not psychoactive, it does seem to behave as a cannabinoid potentiator. What that means is taking THC-M with a psychoactive cannabinoid could potentiate – in other words, strengthen and enhance – the ‘high’.  Theoretically, then, combining, say, THC-M with THC-P would make THC-P more intoxicating, by enhancing its ability to bind to cannabinoid receptors and allow the full extent of its effects to be felt throughout the body and mind. Keep in mind again that THC-M is such a new cannabinoid that we can’t say for certain it doesn’t offer a high.  It’s just that it’s unlikely.  As more research is done, we hope to understand this property much better than we do now.  And, you won’t find any pure THC-M products on the market for now, which would allow you to test those effects for yourself, since demand just doesn’t exist at this point in time. So, what about specific benefits of THC-M, like effects related to pain, sleep, anxiety, etc.?  Again, we just don’t know. Without clinical research or extensive anecdotal information, we can’t really make any claims about THC-M’s benefits in a way that’s responsible. But, we can look at the potentiating nature of THC-M to get an idea.   Taking THC-M with a cannabinoid known for its benefits would, theoretically, enhance the benefits of the latter, so that’s something to keep in mind if you’re using hemp for therapeutic rather than recreational purposes. The laws surrounding cannabinoids can get tricky on a state level, but THC-M is completely legal according to federal law.  That’s because it complies with the 2018 Farm Bill, which states that all hemp products containing a maximum of 0.3% delta 9 THC are legal. THC-M is not delta 9 THC, and so there are no restrictions when it comes to how products can be sold. THC-M can exist in any concentration without any limitations. One thing to bear in mind is that 20 states have banned THC-M cannabinoids, and even though THC-M probably isn’t intoxicating, it is banned in: So, if you live in one of these 20 states, unfortunately, you can’t purchase THC-M at this time. Basically, for now, you’re only going to find mainly THC-M vapes, featuring cannabinoid blends.  We said before that it’s common to pair THC-M with intoxicating cannabinoids to offer a stronger high than you’d get from the cannabinoid alone.  Aside from vapes, you may come across the occasional gummy that features a cannabinoid blend containing THC-M. Overall, the same rules apply when shopping for THC-M as with any hemp product. Look for lab reports, and only buy from trusted brands with lots of great reviews. Right now, Binoid is working on THC-M products through their super popular cannabinoid blends line, so we recommend keeping an eye out, as Binoid is a highly trusted brand on the hemp market. THC-M is not a cannabinoid you’d necessarily try on its own, but it’s hard to resist the new products coming out that throw THC-M in with other cannabinoids we already know and love.  If you’re ready to give this potentiator a try, stick to a brand you can trust, already highly regarded for their super effective, top-quality products, like Binoid. This way, you’ll know you’re getting only a legitimate, clean, and lab-tested product that gives you the full potential of what THC-M can offer. And don’t forget to use the code HIGHTIMES25 for 25% off while being treated to fast shipping so that you can get acquainted with this fascinating cannabinoid in no time flat. To buy THC-M Cannabinoid Products Click Here

https://hightimes.com/

From Murder Capital to Vacation Destination: Exploring the New El Salvador

“You know who lives there?” Charlie, the man driving our boat, asks me as I jump into the deep blue water of Lake Coatepeque in northwestern El Salvador. He points to a minimalist-style villa on the freshly-mowed slopes of an island at the center of the lake. “That’s President Bukele’s. Ocho million dollares!” In any other Latin American country, people would talk about their leader’s private wealth with scorn. But Charlie’s tone is one of praise, excitement, even pride. It’s a sentiment I encountered again and again while traveling through El Salvador, and for a good reason. Until recently, the country was known and feared as the “murder capital” of planet Earth, with 1 in every 10,000 residents falling victim to homicide. Today, four years after Nayib Bukele assumed office, the number of annual killings has dropped from 5,000 to just 495: a statistic that has earned him the lifelong gratitude of his constituents. “I can finally go outside without worrying,” a student from Universidad Don Bosco in Soyapango, previously the most dangerous suburb in the capital city of San Salvador, told me. “It still doesn’t feel real.”  Born to a Muslim family that emigrated from Palestine, Bukele served as the mayor of San Salvador before setting his eyes on the presidency. A dark horse candidate, his anti-establishment, anti-corruption agenda allowed him to score a surprise victory against El Salvador’s entrenched elite. Many presidential candidates in Latin America promise to “drain the swamp” and put an end to the corruption that keeps their countries impoverished and oppressed, only to become a part of the establishment they vowed to tear down. Bukele is the rare example of a politician that not just kept his word, but managed to hold onto power while doing so.  One of Bukele’s top priorities was to hunt down El Salvador’s biggest gangs, Mara Salvatrucha (MS-13) and 18th Street, which earn money through prostitution, drug smuggling, human trafficking, and transporting aliens across the U.S.-Mexican border. The government’s pursuit of the gangs resembles less of a crackdown than it does an all-out war. To this day, tens of thousands of heavily-armed soldiers are regularly mobilized to besiege and infiltrate criminal strongholds.  Drastic problems require drastic measures, and Bukele’s was to arrest and imprison anybody who had even the slightest affiliation with the criminal underworld. As of 2023, more than 72,000 Salvadorians have been taken off the streets and stuffed into the country’s already overcrowded prisons.  Bukele’s policies on crime, while effective, come at a cost. While the state has managed to round up many dangerous offenders, it also detained a significant number of individuals who – after close examination – turned out to be completely innocent. Gabriela, a lifelong resident of San Salvador and tech entrepreneur I met at a Miami-esque beach party in the surfer town of El Tunco, told me how, one day, her private driver stopped answering his phone. After contacting his sister, she learned he had been taken by the police while standing on the street drinking Pilsner – El Salvador’s national beer – with former gang members. Accusing Bukele of human rights abuse, journalists and activists argue mass imprisonment won’t solve El Salvador’s problems but only make them worse. His proponents beg to differ: by cleaning up the streets, the president is able to develop public works that will improve the country’s economy and infrastructure. While highways and libraries can’t justify the injustice suffered by Gabriela’s driver, traveling through this new and improved, and above all, safer, version of El Salvador is making me kind of agree with the average citizen that these are, to an extent, necessary sacrifices. “I do not agree with everything Bukele does,” was the standard response I kept hearing from people, “but we are doing better than we were in the past – and that makes me feel hopeful about tomorrow.” Where so many corruption-stricken Latin American countries live in an inescapable present, El Salvador is able to look towards the future. In addition to his war on crime, Bukele is best known for his embracement of cryptocurrency. Shortly after setting up shop in San Salvador’s casa blanca, the 42-year-old leader surprised the world by investing a sizeable portion of government funding in Bitcoin. In hindsight, the decision wasn’t all that surprising. The crypto craze was at an all-time high back then, and with Bitcoin’s value on the rise, Bukele saw an opportunity and must have thought he was about to triple the country’s coffers, even quadruple the amount of money he’d put in. Unfortunately, his announcement came moments before the crash of FTX and the federal investigation of its CEO, Sam Bankman-Fried: events that set the crypto world on a downward spiral it has yet to escape from. While exact numbers are hard to come by, El Salvador is rumored to have lost upwards of $70 million. You’d think such a blunder would damage the country’s economy, not to mention Bukele’s credibility, but that does not seem to be the case. In contrast to neighboring Guatemala, where a despotic Attorney General is currently attempting to undo the ascension of a democratically elected, left-leaning president with an agenda not unlike that of his Salvadorian counterpart, El Salvador remains stable, peaceful, even prosperous. One of the biggest benefits of Bukele’s war on crime is that the resulting safety opened the country up to an industry that had hitherto been all but non-existent there: tourism. At Coatepeque, construction workers are building a litany of hotels, hostels, and clubs to accommodate growing numbers of travelers. Still more projects are in the works at Lake Llopango, located outside San Salvador.  “This place used to be extremely dangerous,” Gabriela told me as we walked up to a breathtaking mirador, or viewpoint, looking over a thick and seemingly endless canopy. “It’s where all the gangs from Soyapango went to hide.”  More confused than concerned, I glance over at two soldiers standing guard, their fingers on the triggers of their loaded shotguns. Laughing, Gabriela informs me that their presence is purely ceremonial: Bukele, needing to maintain the standing army he’s amassed for his war, sends troops across the country to act as glorified bodyguards. Not to protect visitors from kidnappers – those odds, she says, are low – but so they have something to do until they are called to lay siege to the next criminal hideout.  Though not as large as Guatemala and Honduras to the north, or as environmentally diverse as Nicaragua and Costa Rica to the south, El Salvador has much to offer the curious traveler. There’s Santa Ana, a colonial city near the Guatemalan border from where you can visit Coatepeque and climb the Santa Ana volcano, filled not with lava but with pools of boiling water. There’s El Tunco, the aforementioned surf town where you can test your skills on some of the largest, longest, roughest waves you’ve ever seen – or watch others do it from the beach.  Aside from the grueling traffic, San Salvador is a surprisingly organized capital where neon-lit hipster cafes share parking spaces with hole-in-the-wall pupuserias – barebone cafeterias serving El Salvador’s signature dish: thick tortillas made from corn or rice, stuffed with cheese, pumpkin, spinach, or chicharron, to name only a handful of ingredients.  While exploring El Salvador is no longer life-threatening, it’s still very adventurous. If you want to get from one place to another, you usually cannot book a private shuttle. Instead, you will have to hop on a public “chicken” bus, retired American school buses the U.S. government deemed too old and broken to transport children, but were given a second life in Central America. In many towns, you also have the opportunity to rent motorcycles. If you have never ridden one before, don’t worry – they neither require a license nor experience, and the roads of El Salvador are so chaotic that you’ll become a pro by the time you make it to your destination. That is, so long as you weren’t sent flying by some knee-deep pothole or camouflaged speed bump.  The biggest adrenaline rush (or panic attack) I had in El Salvador was a group tour of the Siete Cascadas or Seven Waterfalls near the town of Juayua, a 1 hour motorbike ride south of Santa Ana, where what I had expected to be a calm and peaceful stroll quickly turned into something out of the survival novel Robinson Crusoe. Walking barefoot through a jungle infested with spiders, snakes, and crabs – yes, crabs – I was so taken aback by the absurdity of my predicament that I didn’t even think to object when my tour guide (a 9-year-old, crab-catching boy called Cristian) told us to climb up the waterfalls rather than go around them. “I don’t think this tour was approved by the Salvadorian Health and Safety Department,” I half-joked, latching on to the slippery, moss-covered rocks and praying I would live another day.  As much as I ended up enjoying my stay, I originally didn’t plan on visiting El Salvador. Although I had heard of what Bukele was doing, I still pictured the country as it was in the past, the way it looked when I saw it on the news, or in an episode of World’s Toughest Prisons. Instead, I thought that I would spend more time in what the media portrayed as its safer, friendlier neighbor: Guatemala. Ironically, it was Guatemala that proved to be more unpredictable as, mere days after I entered El Salvador, rightfully-outraged Guatemalans clashed with law enforcement and barricaded the borders. Weeks later, they still haven’t managed to stop the old government from persecuting their president-elect. But that’s a different story. 

https://hightimes.com/

Former Tesla Employee Funds Multi-Million Dollar Harvard Psychedelic Program

Harvard will soon implement a new program of study dedicated to the use of psychedelics and how they impact various facets of the modern day, thanks to an eight-figure grant from a former Tesla employee. According to a news release, Harvard University will begin teaching a new multidisciplinary study of “Psychedelics in Society and Culture.” The course was funded by a $16 million grant from the Gracias Family Foundation, started by former Tesla employee and CEO of Valor Equity Partners, Antonio Gracias.  Gracias, a long time friend and colleague of Tesla CEO Elon Musk was a director at Tesla from 2007-2021. A Quartz article said  Gracias’ firm also served as an informal CEO of Twitter after Musk fired the original CEO immediately after acquiring the social media giant. The news release from Harvard said that the Gracias Family Foundation is interested in the potential of using psychedelics for therapeutic use as well as applying funding to such endeavors.  “Harvard is the ideal place to explore the topic of psychedelics from new angles, and to craft a framework for their legal, safe, and appropriate impact on society,” Gracias said in a statement. The news release from Harvard said that the new psychedelic-oriented program will be taught as a joint effort between the Faculty of Arts and Sciences, Harvard Law School, and Harvard Divinity School. The program will seek to apply Harvard’s record of excellence and professionalism to a topic often marred in mysticism and bro science partially leftover from the somewhat messy psychedelic and psychedelic-adjacent movements of the 1960’s. In Harvard’s own words, the program “seeks to transform the psychedelics research landscape by producing cutting-edge scholarship and convening faculty, students, and experts to engage in discussion around their far-reaching implications.” “We are thrilled to have the opportunity to bring students, faculty, and researchers together around the important issue of how psychedelics impact our society,” said Robin Kelsey, Shirley Carter Burden Professor of Photography and dean of arts and humanities. “Harvard is uniquely poised to become the most exciting place to debate, discuss, and innovate in this area.” The new Harvard program would not be considered the first psychedelic-based area of study at an American university as several psychedelic-based credential programs already exist at certain other colleges but this certainly marks a monumental announcement from an Ivy League University of Harvard’s caliber. The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School also started an initiative in 2021 called the Project on Psychedelic Law and Regulation (POPLAR) to study psychedelics’ “ethical legal and social implications.” The recent news was hailed by many as much-needed progress in the development of psychedelic education, including Michael Pollan, long-time psychedelic advocate and author of several books on the topic including “How to Change Your Mind” which was later made into a Netflix series.  “This is a visionary gift, in that it is the first to take the so-called psychedelic renaissance beyond medicine, by recognizing the importance of the humanities in exploring the impact and potential of these remarkable substances,” Pollan said in a written statement.  It was not immediately clear based on the news release specifically when the new program would be available to Harvard students or what sort of curriculum would be applied to a relatively new and still-emerging field of study. The news release did indicate that the program would “approach the field from a range of humanistic and social scientific viewpoints including law, policy, ethics, religion and spirituality, the nature of consciousness, and art and literature.” The news release also said that the $16 million from the Gracias Family Foundation would additionally be used to help fund  the expansion of existing programs at the Harvard Center for the Study of World Religions as well as funding new fellowships at the CSWR and the Mahindra Humanities Center.  “One of Harvard’s greatest strengths is our ability to bring together experts from various fields to engage in vibrant discussions that advance scholarship from multiple angles,” said Bruno Carvalho, interim director of the Mahindra Humanities Center. “This initiative will give us the space to explore and enrich public dialogue around psychedelics, including their potentials, as well as ethical and social implications.”

https://hightimes.com/

Paul McCartney-Signed Pot Arrest Cartoon Appears on Antiques Roadshow, Valued Up to $3,600

A cartoon depicting Paul McCartney being searched for pot by airport customs and with an autograph from the singer appeared on Antiques Roadshow season 46, episode 2 on Sunday, Oct., 5. The cartoon was valued between £2,000 – 3,000 ($2,437.12 – 3,655.71 USD). On the episode, Antiques Roadshow traveled to Crystal Palace Park in the heart of southeast London, revealing all sorts of treasures including a cigar once belonging to Winston Churchill and vintage Vivienne Westwood outfits. A guest arrived and said her father Pete was a cartoonist for over 30 years, and that one of his cartoons depicted Paul McCartney. The cartoon shows McCartney being searched by airport customs for pot in his luggage—drawn when The Beatles star and his late wife Linda were arrested for 10 grams of pot in 1984 in Barbados. It’s a single-frame cartoon similar to The Far Side. McCartney was apparently amused by it and signed the cartoon, pumping up the cartoon’s valuation dramatically. “Yesterday, all my troubles seemed so far away,” the cartoon reads. Pete drew McCartney being questioned by customs officials and singing sadly. The authorities emptied his luggage and placed what looks like a film canister and a little pile of weed on the table in the cartoon. There’s a newspaper on the floor that reads “Ex-Beatle Barbados Drug Sample…” At the bottom of the cartoon, it says “Play the pipes of peace”, a reference to “Pipes of Peace,” his No. 1 single on the UK Billboard at the time. “Yesterday” is one of 32 No. 1 songs composed or co-written by Paul McCartney—the most covered song of all time, according to Newsweek.  Antiques Roadshow antiques expert and frequent guest Hilary Kay was delighted by the cartoon of The Beatles star. “In turning it over, this is really nice, because it looks like a piece of HMRC notepaper, it’s got the reference there,” Kay said. “So while he was drawing this, Paul McCarney was being interviewed, and then, how come Paul McCartney has signed it?” The guest replied, “I think he just showed him the cartoon, that would have been my dad. He would have said ‘Hey, this is a bit of a tense moment, but this might make you laugh.’ “ Kay then said, “And Paul McCartney would have thought, ‘That’s just great’ and signed it off. How lovely, what a great story. Let’s cut to the chase, there was your dad sketching away, I wonder if he ever thought that it would be valuable?” The guest replied, “He wouldn’t have done, and I can tell you why—my dad hasn’t signed it. It will have been just a quick scribbly thing and I don’t think he would have valued it at all.” Kay said, “Well the market values it highly, because it’s a very interesting incident in McCartney’s career, and it’s too good a story. I think we’re talking about at least two to three thousand pounds. “And I hope that your dad would be really proud.” The daughter said, “I think he would, and I think he’d be proud that I’ve done this today.” You can watch the entire episode here. Inspiring the cartoon, McCartney and his late wife Linda were arrested for possession of 10 grams of pot in Barbados in January 1984 and fined $200 dollars—$100 each. McCartney was arrested frequently for pot, and I profiled his top five pot arrests in 2019, including this one. Undeterred, Linda was fined $105 on January 24—eight days later—on another cannabis charge. For the second charge, Linda was with McCartney at Heathrow Airport on their way back to the U.K. from their vacation in Barbados, and was carrying five grams of weed stuffed in a film canister that they apparently scored during the holiday.  This was nothing compared to his most serious arrest, though, four years earlier: On January 6, 1980, McCartney was caught with 218 grams (7.7 ounces) of “dynamite weed” into Japan at the Narita International Airport. He was locked up in a 4 x 8-foot cell in jail for nine days, and a spokesperson said that the Japan incident set McCartney back $420,000. While still in The Beatles, McCartney also paid the equivalent to a year’s worth of average wages to run an ad demanding that the U.K. legalize pot in a full-page ad to run in The London Times on July 24, 1967. The Beatles and band manager Brian Epstein joined a few dozen activists to urge lawmakers to legalize pot in the U.K. All four band members smoked and liked cannabis—but especially McCartney. “The law against pot is immoral and unworkable in practice,” the ad title reads. Pot is “the least harmful of pleasure-giving drugs, and […] in particular, far less harmful than alcohol.”  McCartney agreed to finance the full-page ad himself, and recruit the band to join in. Steve Abrams contacted Brian Epstein’s office, and shortly afterwards received a personal check from McCartney’s funds for £1,800 made out to The Times–the equivalent to £37,303.23 today, or $51,321.78, modified for inflation. McCartney said that 1966’s “Got to Get You into My Life,” was his first song officially about pot, though he tried it at least two years earlier. This cartoon pays homage to the artist’s troubles with pot.

https://hightimes.com/

Victorian Parliament Okays Medicinal Cannabis Driving Trial

The Victorian parliament has passed new laws that will allow medical cannabis users to get behind the wheel on a closed road. These new laws are part of a trial that will look into the impact marijuana has on a person’s driving ability. In 2016, Victoria was the first Australian state to legalize medical cannabis. However, individuals part of this program can still face legal consequences if they’re found to have tetrahydrocannabinol (THC) in their system while driving. The difficulty with this is THC can remain in a person’s system long after the “high” has worn out. That said, you can find yourself with an offense even if you haven’t consumed it for a few days. As of this time, Tasmania is the only state that allows for a medical defense if THC is found in a driver’s body fluids. This is the primary importance of Victoria’s trial – to determine what’s a safe level of THC to be driving with. Many Victorian medical marijuana users have raised concerns about the risk of losing their license or being fined. The Victoria parliament had initially addressed these concerns in 2021, but efforts were delayed due to COVID-19.  The government plans to commission an independent research organization (currently undetermined) which will be supported by the Department of Transport and Planning. And they’ve made sure to note that this research will take place in a controlled-driving environment that’s separated from public roads. Such efforts couldn’t come at a better time. According to road safety minister, Melissa Horne, the number of medical marijuana patients in Victoria has increased more than 700% over the last 2 years. While Victoria can recognize the many benefits medical cannabis provides to residents, there remain “significant gaps” in their understanding of THC. More specifically, how it affects drivers and what the risk is for road safety. “This bill will allow us to deliver a world-leading research trial into medical cannabis and driving, enhancing our understanding of how cannabis affects driving behaviour and informing future reform,” Horne said. There have been other efforts for reforms to road laws and medical marijuana. For example, upper house MPs Rachel Payne and David Ettershank, of the Legalise Cannabis party, have been championing for it to no longer be an offense if a driver who has detectable levels of THC in bodily fluid is unimpaired. Both Payne and Ettershank support the current trial but are concerned it will take too long. “The reality is patients continue to wait,” Payne said. “Medicinal cannabis has been prescribed since 2016, that’s a long time for patients to have to wait for a resolution.” She continued: “A medicinal cannabis patient should be treated like any other patient who is prescribed medicine by a doctor who also provides appropriate advice about when that patient is safe to drive.” Beyond this information, it would also help to have a way of testing impairment. Since law enforcement can’t resort to surefire results as seen with a blood-alcohol test, it would also benefit Victoria to determine a proper physical test to decide on a driver’s state of intoxication.

https://hightimes.com/

Eastern Band of Cherokee Indians Approves First Medical Cannabis Cards

The Eastern Band of Cherokee Indians (EBCI) is continuing its path toward cannabis accessibility, and as of last week the tribe officially issued its first medical cannabis cards. According to EBCI Cannabis Control Board (CCB) executive director, Neil Denman, a Cherokee Police Commission monthly meeting was held on Oct. 12. In a presentation featuring Denman and his colleague, Kym Parker, they stated that the first medical cannabis card was issued on that day, and many more will follow in the coming weeks. A total of 1,005 medical cannabis card applications were submitted, and so far 817 were approved. Only 129 are labeled as incomplete, due to missing assets such as a photo ID, and 59 were denied because of “lack of a qualifying ailment.” The EBCI live on a 57,000-acre reservation called the Qualla Boundary. The tribe’s website states that they have 14,000 registered tribe members, but the U.S. Census Bureau reports that the reservation is home to 9,600 people, 77% of whom are of Indian descent, and 23% non-Indian. The boundary is also home to two casinos that the tribe manages. The topic of transporting cannabis to its dispensary was called into question by Vice Chairman Joseph Buddy Johnson. For this to happen, the cannabis products must be moved on a state highway through Swain County. According to Denman, they are coordinating with Swain County to put together a transportation plan. The EBCI dispensary hasn’t opened yet, so the medical cannabis cards can’t be used. When the program becomes fully operational, the cards will limit how much daily and/or weekly cannabis that patients can purchase. Should a patient violate those rules, their card will be either suspended or revoked. The cards can also be used by off-boundary members who seek to grow their own cannabis plants at home. Currently there are plans for only one cultivation site at the moment, which is still under construction. In total, the grow will feature 42 hoop houses that will hold 2,040 plants. Eventually, they hope to expand their hoop house number to 69-70. Johnson inquired about plans for a second cultivation site, but Denman explained that the first site is the focus for now. Originally, the EBCI Tribal Council voted to decriminalize cannabis, as well as legalize medical cannabis back in 2021—a historic event considering that this was accomplished prior to the state of North Carolina making significant progress to legalize medical cannabis. By November 2022, EBCI had harvested its first cannabis crop. “It’s a vertical market. We have to plant it. We have to cultivate it. We have to harvest it. We have to process it. We have to package it and move through all of that network of product and get it there. It’s a lot of people,” said Qualla Enterprises LLC general manager, Forrest Parker. One month later, the EBCI Tribal Council agreed to provide Qualla Enterprises with $63 million to properly regulate medical cannabis. “This tribe, I’m so proud of us for putting us in a position to learn from other people’s mistakes so that when we do this right, that number is precise,” Parker said. “It’s not $150 million because we’re trying to cover all these things that we don’t know. We actually feel like we actually know.” In January 2023, the tribe announced that it would be moving forward with its plans to regulate medical cannabis on the reservation. The council voted to introduce their prepared regulations to the North Carolina General Assembly. Principal Chief Richard Sneed spoke at the meeting where the 12-person council approved the regulations, stating that it is of the utmost importance to keep the state legislature in the know. “All this is, is it as a matter of tribal law, before anybody does any work engaging with the state or federal legislature, we have to have permission of the governing legislative body to do so,” Sneed said. In another record decision on Sept. 7, the EBCI tribe members voted in favor of a proposal to permit the sale of recreational cannabis on tribal land as well. “The Council’s approval of a medical marijuana ordinance is a testament to the changing attitudes toward legal marijuana and a recognition of the growing body of evidence that supports cannabis as medicine, particularly for those with debilitating conditions like cancer and chronic pain,” said Sneed. Now the council will move forward with developing legislation to regulate legal cannabis. The Qualla Boundary is currently the only area of North Carolina where medical or recreational cannabis is legal. In July, Senate Bill 3 was introduced, which would have legalized medical cannabis for patients with life-ending illness. While the bill was initially passed in the Senate earlier this year, it didn’t receive support in the House. However, House Speaker Tim Moore announced that the bill was likely dead for 2023. In order for it to pass, it “would require a number of House members who’ve taken a position of ‘no’ to literally switch their position to want to vote for it, and I just don’t see that happening,” Moore explained.

https://hightimes.com/

Study: Legal Pot Retailers Not Linked To Rise In Crime

According to a study published this month in the Annals of Regional Science, the opening of a state-regulated cannabis dispensary “has no significant impact on local crime in the average neighborhood.” If you’re reading this, chances are you didn’t need to be told that –– but feel free to share with someone who does!  The researchers behind the study, affiliated with the University of Hawaii and Johns Hopkins University, examined data from the state of Washington, which joined Colorado in 2012 in becoming the first two states in the country to legalize recreational pot for adults. “Many North American jurisdictions have legalized the operation of recreational marijuana dispensaries. A common concern is that dispensaries may contribute to local crime. Identifying the effect of dispensaries on crime is confounded by the spatial endogeneity of dispensary locations,” the researchers wrote in the study’s abstract. “Washington State allocated dispensary licenses through a lottery, providing a natural experiment to estimate the causal effect of dispensaries on neighborhood-level crime. Combining lottery data with detailed geocoded crime data, we estimate that the presence of a dispensary has no significant impact on local crime in the average neighborhood. We estimate a small rise in property crime in low-income neighborhoods specifically,” they concluded. Previous studies have arrived at the same conclusion. One such study that was published in 2018 looked at “longitudinal data on local marijuana ordinances within California and thoroughly examining the extent to which counties that permit dispensaries experience changes in violent, property and marijuana use crimes using difference-in-difference methods.” “We find no significant impact of dispensaries on violent crime in any of our models,” the researchers wrote in their conclusion. “The consistency of findings regardless of inclusion or exclusion of the county-specific time trend is reassuring, but not surprising in light of the more consistent trends observed across counties in these measures.” They added: “The results suggest no relationship between county laws that legally permit dispensaries and reported violent crime. We find a negative and significant relationship between dispensary allowances and property crime rates, although event studies indicate these effects may be a result of pre-existing trends. These results are consistent with some recent studies suggesting that dispensaries help reduce crime by reducing vacant buildings and putting more security in these areas. We also find a positive association between dispensary allowances and DUI arrests, suggesting marijuana use increases in conjunction with impaired driving in counties that adopt these ordinances, but these results are also not corroborated by an event study analysis.” Another study, published in 2019, examined data out of Denver, Colorado, ultimately finding that the addition of a dispensary in certain neighborhoods led to a reduction in crime.  “The results imply that an additional dispensary in a neighborhood leads to a reduction of 17 crimes per month per 10,000 residents, which corresponds to roughly a 19 percent decline relative to the average crime rate over the sample period. Reductions in crime are highly localized, with no evidence of spillover benefits to adjacent neighborhoods. Analysis of detailed crime categories provides insights into the mechanisms underlying the reductions,” the researchers wrote. “We find that the overall effect of adding a dispensary to a neighborhood of 10,000 residents is a reduction of crime of around 17 crimes per month. In this section, we further analyze and decompose the data in order to provide a better sense of the underlying mechanisms that lead to crime reduction and to compare these findings with existing theories about the effect of legalization on crime…We use a novel identification strategy to show significant crime reductions in neighborhoods that receive marijuana dispensaries. To our knowledge, our research is the first research to use exogenous variation in dispensary locations to identify local crime effects of marijuana dispensaries. We find that adding a dispensary to a neighborhood (of 10,000 residents) decreases changes in crime by 19 percent relative to the average monthly crime rate in a census tract,” they added. Somebody ought to pass these findings along to Republicans on Capitol Hill. Last year, GOP members of the House of Representatives unveiled its “Family Policy Agenda” that emphatically opposed marijuana legalization, contending that ending the prohibition on pot will lead to a spike in violent crime and suicide. Yes, seriously. “Marijuana remains a federally scheduled controlled substance, but that has not stopped more and more states and localities from legalizing it under their own laws,” the agenda read. “Congress should not legalize marijuana, while also taking steps to constrain this new industry’s ability to harm children. At the very least, Congress should direct the CDC to gather data and conduct studies on the health impacts of THC use during childhood and early adolescence with a special focus on deaths by suicide and those involved in violent crime to provide Congress and the public with further information about these dangers.”

https://hightimes.com/

Study: LSD Use On the Rise Among American Business Leaders

A recent analysis of psychedelic drug use among American adults has indicated that business leaders and managers seem to be dropping more acid than their subordinates.  The study, published last Wednesday in the peer-reviewed journal Substance Use and Misuse, analyzed data from the National Survey on Drug Use and Health and looked at trends related to use of lysergic acid diethylamide, commonly known as “LSD,” or “acid.” The study looked at data from over 168,000 adults over the course of the years 2006-2014 and found that people who identified themselves as managers in their field had experienced a notable increase in LSD use in the last year of the study, significantly more so than other full-time employees who did not identify as managers.  “The results suggest that the prevalence of past year LSD use increased over time at a greater rate among business managers than non-managers and that this difference cannot be accounted for by changes in business managers’ perceived risk of LSD use or general substance use relative to non-managers,” the study said.  NSDUH survey responders self-reported their own drug use which included information on psychedelics including LSD. Researchers used this information to form correlations and they found that business managers and leaders experienced a .07% increase in LSD use over the last year of the study whereas other full time employees who were not in a leadership position only increased by .02%. Author of the study and postdoctoral researcher at Germany’s University of Bamberg, Benjamin Korman, told PsyPost that he wanted to embark on this study in order to apply science and logic to a recent resurgence in popularity with regard to classical psychedelic use among American adults. “The number of anecdotal media reports on psychedelic drug use among employees and business leaders have increased dramatically in recent years, though empirical evidence regarding the prevalence of this use was lacking,” Korman said to PsyPost. “My intent was to determine whether these media reports stemmed from skewed reporting or were representative of an actual shift in psychedelic use within the workplace.” Indeed psychedelic use has been on the rise once more, in part due to a new swath of studies and academic interest in the use of psychedelics to treat a barrage of treatment-resistant mental health disorders. In terms of recreational use, the majority of psychedelic use has long been associated with a younger demographic. This is likely the lingering sentiment of Nixon-era propaganda portraying psychedelic users as degenerates and draft-dodgers.  However, the data does reflect that young adults are by far the biggest consumer demographic of psychedelic drugs, although a 2022 study by the Columbia University Mailman School of Public Health found psychedelic use was actually decreasing among adolescents. However, Korman told the PsyPost he wanted to identify trends outside of age-related correlations.  “Although previous research has suggested that psychedelic drug use in the United States is predominantly increasing among young adults, my findings suggest that notable growth in use is also to be found among those at the highest tiers of organizational hierarchies,” Korman said to PsyPost. This data represents a major shift in LSD use, according to the study, as in 2006 LSD use was higher among subordinates than among higher ranking members of company hierarchies. In 2014, managerial LSD use increased at a higher rate than regular employees. This could be due to a myriad of factors including public perception shift with regard to the risks of taking psychedelics that may have made it easier for certain people to try them. However, Korman told PsyPost that his team accounted for several different factors over the course of the study and could not identify a direct causal relationship between risk association and LSD use. Rather, he said the opposite could be true.  “I was surprised that decreasing perceptions of the risks associated with LSD use could not explain the findings,” Korman said. “This suggests that it is not the potential negative effects of LSD that are responsible for differences in use between business managers and non-managers, but maybe perceptions of the potential positive effects of LSD use.” These findings are, naturally, preliminary and subject to more review. It is important to note that the study could not provide any insight on current day LSD trends as the available data stopped in 2014. More research will need to be performed to dispute or verify Korman’s claims and figure out specifically if/why managers might be celebrating Bicycle Day more than their employees.  “In line with my previous comment, one question that remains unanswered is why the prevalence of LSD use among business managers increased,” Korman said to PsyPost. “My study could only show what wasn’t explaining the effect, but not what is.”

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.